WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007022121) O-NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITONS THEREOF AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/022121    International Application No.:    PCT/US2006/031722
Publication Date: 22.02.2007 International Filing Date: 14.08.2006
IPC:
A01N 37/00 (2006.01), A61K 31/21 (2006.01)
Applicants: ATK THIOKOL PROPULSION INC. [US/US] (US) (For All Designated States Except US).
KNOX, Susan [US/US]; (US) (For US Only).
CANNIZZO, Louis [US/US]; (US) (For US Only).
WARNER, Kirsten [US/US]; (US) (For US Only).
WARDLE, Robert [US/US]; (US) (For US Only).
VELARDE, Stephen [US/US]; (US) (For US Only).
NING, Shoucheng [US/US]; (US) (For US Only)
Inventors: KNOX, Susan; (US).
CANNIZZO, Louis; (US).
WARNER, Kirsten; (US).
WARDLE, Robert; (US).
VELARDE, Stephen; (US).
NING, Shoucheng; (US).
BEDNARSKI, Mark, D.;
Agent: TRECARTIN, Richard, F.; DORSEY & WHITNEY LLP, 555 California Street, Suite 1000, San Francisco, California 94104 (US)
Priority Data:
60/707,896 12.08.2005 US
11/502,974 11.08.2006 US
Title (EN) O-NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITONS THEREOF AND USES THEREOF
(FR) COMPOSES O-NITRO, COMPOSITIONS PHARMACEUTIQUES CORRESPONDANTES, ET LEURS UTILISATIONS
Abstract: front page image
(EN)The present invention provides O-nitro compound, pharmaceutical compositions of O-nitro compounds and methods of using O-nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
(FR)La présente invention concerne un composé o-nitro, des compositions pharmaceutiques de composés o-nitro, et des procédés d'utilisation de composés o-nitro et/ou de compositions pharmaceutiques correspondantes pour le traitement ou la prévention d'affections ou de troubles caractérisés par la prolifération de cellules anormales, tels que le cancer, l'inflammation, les maladies cardiovasculaires et les maladies auto-immunes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)